Skip to main content

Table 3 Comparison between the AML patients and controls regarding WT1 expression

From: Wilms tumor 1 gene expression in acute myeloid leukemia: prognostic significance and usefulness in minimal residual disease monitoring—a case–control study

NCN of WT1 gene expression AML patients (n = 40) Controls (n = 15)
Min.–Max 33.0–74,741.0 5.0–1059.0
Mean ± SD 11,109.3 ± 13,387.3 262.13 ± 355.6
Median 7294.0 69.0
IQR 3084.5–14,272.0 35.0–390.0
Significance p < 0.001
  1. p: p value for Mann Whitney test for comparing Group I and group II
  2. Statistically significant at p ≤ 0.05